Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

3.01
Delayed Data
As of Aug 03
 -0.06 / -1.95%
Today’s Change
2.07
Today|||52-Week Range
5.55
+33.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$44.5M

Company Description

Rosetta Genomics Ltd. engages in the discovery, development, commercialization, marketing, and sale of diagnostic tests and therapeutics based on micro-ribonucleic acids (microRNA). It offers proprietary microRNA technologies such as Rosetta Cancer Origin Test, Rosetta Lung Cancer Test, Rosetta Kidney Cancer Test, and Rosetta Mesothelioma Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Contact Information

Rosetta Genomics Ltd.
10 Plaut Street
Rehovot Tel Aviv 76706
P:972732220700
Investor Relations:

Employees

Shareholders

Other institutional3.21%
Mutual fund holders0.50%
Individual stakeholders--

Top Executives

Kenneth A. BerlinPresident & Chief Executive Officer
Ron KalfusChief Financial Officer
E. Robert WassmanChief Medical Officer
Dganit BarChief Scientific Officer
Eti MeiriVice President-Research